| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2024 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 259.21B | 251.42B | 256.01B | 148.41B | 115.18B | 113.48B |
| Gross Profit | 75.89B | 73.91B | 75.21B | 61.85B | 55.44B | 54.55B |
| EBITDA | 13.51B | 12.91B | 12.80B | 8.24B | 5.60B | 6.24B |
| Net Income | 4.03B | 4.53B | 3.64B | 4.11B | 1.81B | 2.73B |
Balance Sheet | ||||||
| Total Assets | 136.74B | 108.14B | 134.56B | 143.71B | 64.50B | 52.63B |
| Cash, Cash Equivalents and Short-Term Investments | 20.98B | 21.26B | 19.16B | 29.65B | 14.78B | 13.07B |
| Total Debt | 50.17B | 42.33B | 52.09B | 51.73B | 22.16B | 13.80B |
| Total Liabilities | 96.48B | 79.07B | 95.07B | 106.31B | 38.36B | 28.76B |
| Stockholders Equity | 31.07B | 27.36B | 30.46B | 29.09B | 24.60B | 22.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.18B | 944.00M | 5.56B | 4.08B | -1.27B |
| Operating Cash Flow | 0.00 | 9.28B | 3.50B | 7.18B | 5.31B | 924.00M |
| Investing Cash Flow | 0.00 | 2.06B | -11.59B | -10.62B | -12.10B | -3.21B |
| Financing Cash Flow | 0.00 | -9.20B | -2.42B | 18.07B | 8.23B | -264.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | ¥51.04B | 10.89 | ― | 0.52% | -1.79% | 27.43% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥13.98B | 16.75 | ― | 3.17% | 5.80% | 1.52% | |
58 Neutral | ¥12.14B | 7.73 | ― | 4.65% | 3.96% | 116.45% | |
58 Neutral | ¥67.66B | 15.39 | ― | 1.48% | 6.48% | 20.06% | |
57 Neutral | ¥122.51B | -40.84 | ― | 3.02% | 3.76% | -35.18% |